|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Assessing the quality of studies in meta-analyses: Advantages and limitations of the Newcastle Ottawa Scale显示文摘One of the most important points in the meta-analyses is certainly represented by the assessment of the quality of the studies included in such research. The meta-analyses are considered the highest level of evidence in science. Also for this reason, the quality of the studies included should be accurately evaluated by standardized tools. The overall results of the metaanalysis depend indeed also on a rigorous evaluation of the studies quality. Among all the possible tools for this complex evaluation, the Newcastle Ottawa Scale(NOS) is one of the most used worldwide, above all for observational studies. In this review, we will discuss the strengths and limitation of the NOS, also on the basis of the branch of science in which it has been applied. | Claudio Luchini Brendon Stubbs Marco Solmi Nicola Veronese | 2017 | World Journal of Meta-Analysis2017，5，4： | 35 |
| 2 | Therapeutic effectiveness of echo-guided percutaneous radiofrequency ablation therapy with a LeVeen needle electrode in hepatocellular carcinoma显示文摘瞄准:在在肝脏硬化症的病人获得肝细胞癌(HCC ) 的坏死调查射频脱离(RFA ) 的结果并且在与 HCC 的复发和对待的病人的幸存的关系估计 RFA 的结果。方法:有 63 HCC 的 56 个连续肝脏硬化症的病人与在 2000 年 5 月和 2004 年 5 月之间的 RFA 被对待。HCC 的直径从 1 厘米到 5 厘米(平均数 2.8 厘米) 。在所有情况中, RFA 用可扩充的针电极(LeVeen 针) 在超声指导下面与经皮的途径被执行。治疗功效和复发与双阶段的螺线被评估计算断层摄影术(CT ) 。结果:在单个或多重的治疗以后的完全的坏死在 96.8% 被完成(61/63 ) 肿瘤。我们在 32.3 个月的吝啬的后续期间在 23 个病人(41%) 在完全的坏死以后观察了复发。复发在 2 个病人(8.6%) 并且在在 21 的不同片断是本地的(91.4%) 。主要复杂并发症发生在 3 个病人(4%) 。在后续时期期间, 32 (57.1%) 病人们死了;15 由于 HCC 的前进, 11 从肝失败, 3 从食道的静脉曲张流血并且 3 从不与肝有关的原因疾病。结论:有 LeVeen 针的 RFA 是为在肝脏硬化症的病人的 HCC<5 厘米的有效、安全的治疗。这治疗多远影响病人的幸存率,还得被建立。建立治疗在不同片断阻止复发变得重要,例如干扰素治疗。 | Luigi Solmi Giovanni Nigro Enrico Roda | 2006 | World Journal of Gastroenterology2006，12，7： | 11 |
| 3 | Modeling of Carrier Mobility Against Carrier Concentration in Arsenic Boron-doped Silicon显示文摘 | Masetti G Severi M Solmi S | 1983 | IEEE Transactions on Electronic Devices1983，30，7： | 1 |
| 4 | Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial somatostatin and gabexate mesylate 显示文摘 | Andriulli A Solmi L Loperfido S | 2004 | Clin Gastroenterol Hepatol2004，2，8： | 1 |
| 5 | Search for epithelial-specific mRNAs in peripheral blood of patients with colon cancer by RT-PCR显示文摘 | Solmi R De Sanctis P Zucchini C | 2004 | Int J Oncol2004，25，4： | 1 |
| 6 | High-concentration boron diffusion in silicon:Simulation of the precipitation phenomena显示文摘 | Solmi S Landi E Baruffaldi F | | 0，，07： | 1 |
| 7 | Ultrasound-guided fine needle biopsy of pancreatic masses:results of a mul-ticenter study显示文摘 | Di Stasi M Lencioni R Solmi L | 1998 | Am J Gastroenterol1998，93，8： | 1 |
| 8 | The role of ultrasound in biliary and pancreatic diseases显示文摘 | Lionello Gandolfi Francesco Torresan Luigi Solmi Annalisa Puccetti | 2002 | European Journal of Ultrasound2002，，3： | 1 |
| 9 | Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: A multicenter, placebo-controlled, randomized clinical trial显示文摘 | Angelo Andriulli Rocco Clemente Luigi Solmi Vittorio Terruzzi Renzo Suriani Angelo Sigillito Gioacchino Leandro Pietro Leo Giovanni De Maio Francesco Perri | 2002 | Gastrointestinal Endoscopy2002，，4： | 1 |
| 10 | Modeling of car- rier mobility against carrier concentration in Arsenic-, Phosphorus-, and Boron-doped silicon 显示文摘 | MASETTI G SEVERI M SOLMI S | 1983 | IEEE Trans- actions on Electron Devices1983，30，7： | 1 |
| 11 | Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a malticenter, placebo-controlled, randomized clinical trial 显示文摘 | ANDRIULLI A CLEMENTE R SOLMI L | 2002 | Gastrointest E ndosc2002，56，4： | 1 |
| 12 | The role of ultrasound in biliary and pancreatic diseases 显示文摘 | GANDOLFI L TORRESAN F SOLMI L | 2003 | Eur J Ultrasound2003，16，3： | 1 |
| 13 | Narural history of heparic hemangio- mata : elinieal and ultrasound study 显示文摘 | Gandolfi L Leo P solmi L | 1991 | Gut1991，32，6： | 1 |
| 14 | Results of endoscopic in the treatment of biliary tract complications after orthotopic liver transplantation: our experience 显示文摘 | Solmi L retrograde Cariani G Leo P | 2007 | Hepatogastroenterology2007，54，76： | 1 |
| 15 | Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial显示文摘 | Andriulli A Clemente R Solmi L | 2002 | Gastrointest Endosc2002，56，4： | 1 |
| 16 | Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate显示文摘 | Andriulli A Solmi L Loperfido S | 2004 | Clin Gastroenterol Hepatol2004，2，： | 1 |
| 17 | Natural history of hepatic haemangiomas: clinical and ultrasound study显示文摘 | Gandolti L Leo P Solmi L | 1991 | Gut1991，32，6： | 1 |
| 18 | The role of ultrasound in biliary and pancreatic diseases 显示文摘 | Gandolfi L Torresan F Solmi L | 2003 | Eur J Ultrasound2003，16，3： | 1 |
| 19 | Alumi- num-silicon ohmic contact on ~hallow' n+/p junc- tions显示文摘 | FINETTI M OSTOJA P SOLMI S | 1980 | Soil&State Electronics1980，23，： | 1 |
| 20 | Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis A multicenter, placebo-controlled, randomized clinical trial显示文摘 | Andriulli A Clemente R Solmi L | 2002 | Gastroenterol Endoscopy2002，56，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员